blog
Last updated: 2021-04-23

(Immune Cell Therapy) Personalized Cancer Vaccines

S
Medical Supporter Team
Cross-border medical coordination and editorial review team
(Immune Cell Therapy) Personalized Cancer Vaccines

(Immune Cell Therapy) Personalized Cancer Vaccines

Medical Supporter — Information Notice

This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.

Any specific treatment plan must be assessed by a licensed physician in Japan
  • March 26, 2020
  • Read time: 1 minute

Updated: April 3, 2020

This video was produced by MD Anderson Cancer Center. Dr. Gregory Lizee and his team are designing personalized vaccines that direct the immune system toward a patient's tumor, to treat colorectal cancer patients. Through analysis, 10 cancer-specific targets unique to each patient are identified and incorporated into personalized cancer vaccines.

The goal of immunotherapy is to generate a more powerful anti-tumor response without damaging normal tissue. In the video, Lizee explains how to identify patient-specific targets, why personalized treatment is important, and how this approach can be applied to other types of cancer.

Medical Supporter's official website also provides a summary of related immunotherapy information.

Video source: https://www.youtube.com/watch?v=4DBrxcyo2F8&t=15s

Medical Supporter was formerly certified as an international medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).

Considering medical care in Japan? Need information and support?

We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.

Fukuoka HQ: +81-92-409-5655
Formerly officially certified, No. B-066

Figure 1Figure 1

Figure 2Figure 2

Figure 3Figure 3

Figure 4Figure 4

Related Cancer Information

Related Reading